<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">3690</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url">http://dx.doi.org/10.31782/IJCRR.2021.13922</article-id><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>Central Corneal Thickness in Diabetics and its Relation with Severity of Diabetic Retinopathy and Hyperglycemia Assessed by Glycosylated Hemoglobin in Central India&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tirkey</surname><given-names>Eva Rani</given-names></name></contrib><contrib contrib-type="author"><name><surname>Adlakha</surname><given-names>Neha</given-names></name></contrib><contrib contrib-type="author"><name><surname>Chalisgaonkar</surname><given-names>Charudatt</given-names></name></contrib><contrib contrib-type="author"><name><surname>Khairnar</surname><given-names>Kailash</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>7</day><month>05</month><year>2021</year></pub-date><volume>)</volume><issue/><fpage>40</fpage><lpage>45</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Introduction: Diabetes Mellitus is the leading cause of blindness as a result of complications due to diabetic retinopathy. The metabolic status of the cornea is affected by changes in blood glucose levels. Metabolic stress due to hyperglycemia can alter central corneal thickness.&#13;
Objective: To compares central corneal thickness (CCT) in diabetics and non-diabetic controls and evaluates the relation of CCT with glycemic status and severity of diabetic retinopathy.&#13;
Methods: 180 subjects(93 diabetics and 87 non-diabetics) attending or referred to the Department of Ophthalmology of a tertiary care hospital were included in the study.CCT was measured in all subjects using an ultrasonic pachymeter.&#13;
Results: 93 patients were diabetic(Type 1 four and type 2 eighty-nine) of which 35 patients had no diabetic retinopathy,44 patients had non-proliferative diabetic retinopathy and 14 patients had proliferative diabetic retinopathy. Mean CCT in diabetics(563.11__ampersandsignmu;m __ampersandsignplusmn;11.40__ampersandsignmu;m)was found to be greater than non-diabetics (529.53__ampersandsignplusmn;17.91__ampersandsignmu;m)and the difference was statistically significant (p__ampersandsignlt;0.0001). Mean CCT in type 1 and type 2 DM patients was 562__ampersandsignplusmn;12.90__ampersandsignmu;m and 562.59__ampersandsignplusmn;9.44__ampersandsignmu;m respectively. There were 35 diabetic patients with good metabolic control(HbA1C __ampersandsignlt;7%) who had mean CCT 559.03__ampersandsignplusmn;8.32__ampersandsignmu;m.41 patients with poor metabolic control(HbA1C__ampersandsignge;7) had a mean of CCT 565.04__ampersandsignplusmn;9.94__ampersandsignmu;m and the difference was statistically significant. Mean CCT in patients with no diabetic retinopathy, in patients with non-proliferative diabetic retinopathy and proliferative diabetic retinopathy was 558.81 __ampersandsignplusmn; 7.67um,563.81 __ampersandsignplusmn; 12.32 and 563.43 __ampersandsignplusmn; 9.70um respectively and the difference was not statistically significant.&#13;
Conclusions: A significant correlation was found between an increase in CCT and diabetes, with the positive correlation between thick cornea and duration of diabetes, indicating that patients with thick corneas are more likely to be found in the advanced stage of the disease. Measuring CCT in diabetic patients should be mandatory in the workup of refractive surgery, for donor tissue evaluation before keratoplasty, glaucoma suspects, contact lens users etc. This may help to identify patients at higher risk of developing severe complications, enabling ophthalmologists to treat their disease more accurately.&#13;
</p></abstract><kwd-group><kwd>Central corneal thickness</kwd><kwd> Complications</kwd><kwd> Diabetes Mellitus</kwd><kwd> Glycosylated Hemoglobin</kwd><kwd> Keratoplasty</kwd><kwd> Ultrasonic Pachymeter</kwd></kwd-group></article-meta></front></article>
